Stockreport

In NIH-Cosponsored Monkeypox Virus Study In Congo, SIGA Technologies' Antiviral Tecovirimat Did Not Improve Lesion Resolution, Stock Tanks [Yahoo! Finance]

SIGA Technologies Inc.  (SIGA) 
US:NASDAQ Investor Relations: investor.siga.com/investor-relations
PDF preliminary analysis of the PALM 007 trial of tecovirimat for the treatment of monkeypox virus (mpox) SIGA Technologies (NASDAQ: SIGA ) sells tecovirimat under Tpoxx, [Read more]